We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
(+16%)
Cap. Flow
+$7.6B
Cap. Flow
% of AUM
5.51%
Top 10 Holdings %
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.28B |
| 2 |
Microsoft
MSFT
|
+$517M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$351M |
| 4 |
Apple
AAPL
|
+$302M |
| 5 |
Wells Fargo
WFC
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$685M |
| 2 |
Vanguard Extended Market ETF
VXF
|
+$566M |
| 3 |
Entergy
ETR
|
+$367M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$340M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.22% |
| 2 | Technology | 11.9% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 7.32% |
| 5 | Communication Services | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WRK
1126
DELISTED
WestRock Company
WRK
| $16.7M | 0.01% |
388,414
-82,859
| -18% | -$3.23M |
|
|
RARX
1127
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $16.7M | 0.01% |
355,090
+310,704
| +700% | +$13.7M |
|
1128
Raymond James Financial
RJF
$33.8B
| $16.6M | 0.01% |
278,882
+23,165
| +9% | +$1.34M |
|
1129
Perrigo
PRGO
$1.4B
| $16.6M | 0.01% |
321,892
+5,900
| +2% | +$309K |
|
1130
Fate Therapeutics
FATE
$286M
| $16.6M | 0.01% |
849,401
+3,798
| +0.4% | +$60.3K |
|
|
SIVB
1131
DELISTED
SVB Financial Group
SIVB
| $16.6M | 0.01% |
66,169
-53,292
| -45% | -$12.1M |
|
1132
PUT
Autodesk
ADSK
$49.5B
| $16.6M | 0.01% |
90,300
-36,700
| -29% | -$5.95M |
|
1133
CALL
MGM Resorts International
MGM
$11.4B
| $16.6M | 0.01% |
497,700
-215,500
| -30% | -$6.57M |
|
|
DISCK
1134
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $16.6M | 0.01% |
542,866
+51,504
| +10% | +$1.44M |
|
1135
PUT
Valero Energy
VLO
$90.1B
| $16.5M | 0.01% |
176,500
+120,000
| +212% | +$11.3M |
|
|
ICPT
1136
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $16.5M | 0.01% |
133,315
-23,144
| -15% | -$2.07M |
|
1137
Popular Inc
BPOP
$11.2B
| $16.5M | 0.01% |
281,173
+55,487
| +25% | +$3.1M |
|
1138
CALL
Occidental Petroleum
OXY
$56.8B
| $16.5M | 0.01% |
400,000
-14,500
| -3% | -$581K |
|
1139
iShares MSCI Indonesia ETF
EIDO
$480M
| $16.5M | 0.01% |
642,115
+548,521
| +586% | +$13.7M |
|
1140
PUT
US Bancorp
USB
$98.2B
| $16.5M | 0.01% |
277,600
| – | – |
|
1141
Afya
AFYA
$1.31B
| $16.5M | 0.01% |
606,850
+497,086
| +453% | +$13.4M |
|
1142
Fomento Económico Mexicano
FMX
$43.6B
| $16.4M | 0.01% |
173,355
+12,152
| +8% | +$1.12M |
|
1143
Encore Capital Group
ECPG
$2.02B
| $16.3M | 0.01% |
462,308
-2,219
| -0.5% | -$77.6K |
|
|
HDS
1144
DELISTED
HD Supply Holdings, Inc.
HDS
| $16.3M | 0.01% |
405,903
+157,058
| +63% | +$6.25M |
|
1145
CALL
Applied Materials
AMAT
$403B
| $16.3M | 0.01% |
267,400
+55,100
| +26% | +$3.1M |
|
|
ATH
1146
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $16.3M | 0.01% |
346,893
-249,714
| -42% | -$10.9M |
|
1147
Imperial Oil
IMO
$62.7B
| $16.3M | 0.01% |
615,575
+86,867
| +16% | +$2.2M |
|
1148
Unilever
UL
$137B
| $16.3M | 0.01% |
252,929
+233,149
| +1,179% | +$15.5M |
|
1149
GSK
GSK
$104B
| $16.2M | 0.01% |
276,506
+192,544
| +229% | +$10.7M |
|
|
SPR
1150
DELISTED
Spirit AeroSystems
SPR
| $16.2M | 0.01% |
222,632
+31,533
| +17% | +$2.6M |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2019 Portfolio in Review
As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.
- Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
- Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
- Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
- Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
- Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
- Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.